Who owns Zarxio?
Zarxio is owned by Sandoz (Switzerland, SIX: SDZ).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Sandoz Group AG Integrated Annual Report 2025. Last checked .
Key facts
- Current owner
- Sandoz Group AG reported
- Owner HQ
- 🇨🇭 Switzerland, Basel
- Origin
- 🇨🇭 Switzerland
- Founded
- 2009
- Category
- Healthcare & pharma › Drug makers › Generics & biosimilars
- Parent ticker
- SIX: SDZ
- Last verified
- · 1 sources
About Zarxio
Zarxio, sold as Zarzio in Europe, is Sandoz's biosimilar filgrastim, used in supportive care for cancer patients. It launched in Europe in 2009, and in 2015 it became the first biosimilar approved in the United States. The 2025 annual report says Sandoz introduced it there that year, ahead of every other biosimilar maker.
Ownership timeline of Zarxio
Where Zarxio sits in Sandoz
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Sandoz ownership tree →
See the full Sandoz brand portfolio (14) →
Other brands owned by Sandoz
Sandoz controls 14 brands on Brandtree, 14 of them in healthcare & pharma.
Also in healthcare & pharma
Other brands in generics & biosimilars, and who owns them
Sandoz has more brands in generics & biosimilars on Brandtree than any other owner: 14 of 18.
| Brand | Owner | Owner based in |
|---|---|---|
| Amneal | Amneal | 🇺🇸 United States |
| Nise | Dr. Reddy's | 🇮🇳 India |
| AvKARE | Amneal | 🇺🇸 United States |
| Omez | Dr. Reddy's | 🇮🇳 India |
About the owner: Sandoz
Sandoz is a publicly listed company headquartered in Basel, Switzerland, founded in 1886. Brandtree records 14 brands under its control, and it is listed as SIX: SDZ.
Sandoz is a Basel generics and biosimilars company that traces itself to the business Alfred Kern and Edouard Sandoz founded 140 years before 2026. Sandoz and Ciba-Geigy merged into Novartis in 1996; Sandoz was later re-established as Novartis's generics and biosimilars arm and was spun off on 4 October 2023, when its shares began trading on the SIX Swiss Exchange. Its 2025 net sales were USD 11,086 million, of which biosimilars were 30%.
🇨🇭 Zarxio and other Swiss brands
Brandtree records a controlling owner for 128 brands that began in Switzerland. 35 of them (27%) are now controlled by a company headquartered in another country; Zarxio is not one of them.
- Bemfola — Richter 🇭🇺
- ASTRO Gaming — Logitech 🇨🇭
- Aktifit — Emmi 🇨🇭
- Andermatt-Sedrun — Vail Resorts 🇺🇸
- Artevia — Holcim 🇨🇭
- AutoScout24 (Switzerland) — SMG Swiss Marketplace Group 🇨🇭
Frequently asked questions
Who is the parent company of Zarxio?
The parent company of Zarxio is Sandoz, a publicly listed company headquartered in Switzerland.
Is Zarxio Swiss?
Yes. Zarxio originated in Switzerland in 2009 and its owner, Sandoz, is also headquartered in Switzerland.
Is Zarxio still owned by Sandoz?
Yes. As of 21 October 2026, Zarxio is still owned by Sandoz. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Sandoz Group AG Integrated Annual Report 2025 — Sandoz Group AG, Annual report; retrieved 21 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.